Analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock.
BACKGROUND The guidelines on control and prevention of tuberculosis in the United Kingdom have been reviewed and updated. METHODS A subcommittee was appointed by the Joint Tuberculosis Committee (JTC) ...
Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...
Reviewing literature of rifampin-induced AKI, [4,11–13] the mean age of reported cases is around 40–45 years and the recovery rate ranges from 83% to 96%. However, the incidence to rifampin ...